The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Temporal and Spatial Analysis of Clinical and Molecular Parameters in Dextran Sodium Sulfate Induced Colitis
Open accessAbstract
BACKGROUND: Inflammatory bowel diseases (IBD), including mainly ulcerative colitis (UC) and Crohn's disease (CD), are inflammatory disorders of the gastrointestinal tract caused by an interplay of genetic and environmental factors. Murine colitis model induced by Dextran Sulfate Sodium (DSS) is an animal model of IBD that is commonly used to address the pathogenesis of IBD as well as to test efficacy of therapies. In this study we systematically analyzed clinical parameters, histological changes, intestinal barrier properties and cytokine profile during the colitic and recovery phase. METHODS: C57BL/6 mice were administered with 3.5% of DSS in drinking water for various times. Clinical and histological features were determined using standard criteria. Myeloperoxidase (MPO) activity, transepithelial permeability and proinflammatory mediators were determined in whole colon or proximal and distal parts of colon. RESULTS: As expected after administration of DSS, mice manifest loss of body weight, shortening of colon length and bloody feces. Histological manifestations included shortening and loss of crypts, infiltration of lymphocytes and neutrophil, symptoms attenuated after DSS withdrawal. The MPO value, as inflammation indicator, also increases significantly at all periods of DSS treatment, and even after DSS withdrawal, it still held at very high levels. Trans-mucosal permeability increased during DSS treatment, but recovered to almost control level after DSS withdrawal. The production of proinflammatory mediators by colonic mucosa were enhanced during DSS treatment, and then recovered to pre-treated level after DSS withdrawal. Finally, enhanced expression of proinflammatory mediators also revealed a different profile feature in proximal and distal parts of the colon. CONCLUSION: Experimental colitis induced by DSS is a good animal model to study the mechanisms underlying the pathogenesis and intervention against IBD, especially UC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & Nakaya, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,401
Clinicopathologic study of dextran sulfate sodium experimental acute colitis
Shichijo, K., Matuu, M., Ikeda, Y., Naito, S., Ito, M., & Sekine, I. (1998) · Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)41298-5 · Cited by 1,943
Hapten-induced model of chronic inflammation and ulceration in the rat colon
Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., & Wallace, J. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90904-9 · Cited by 1,829
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., & Kollias, G. (1999) · Immunity · doi:10.1016/s1074-7613(00)80038-2 · Cited by 1,344
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
Experimental models of inflammatory bowel disease
Elson, C. O., Sartor, R. B., Tennyson, G. S., & Riddell, R. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90599-5 · Cited by 1,212
Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J.-P., & Taurog, J. D. (1990) · Cell · doi:10.1016/0092-8674(90)90512-d · Cited by 1,005
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80069-q · Cited by 718
Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor
Mashimo, H., Wu, D.-C., Podolsky, D. K., & Fishman, M. C. (1996) · Science · doi:10.1126/science.274.5285.262 · Cited by 701
Yamamoto, S., Shimizu, S., Kiyonaka, S., Takahashi, N., Wajima, T., Hara, Y., Negoro, T., Hiroi, T., Kiuchi, Y., Okada, T., et al. (2008) · Nature Medicine · doi:10.1038/nm1758 · Cited by 622
Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
Sartor, R. B. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90614-9 · Cited by 584
A porous defense: the leaky epithelial barrier in intestinal disease
Clayburgh, D. R., Shen, L., & Turner, J. R. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700050 · Cited by 498
Furuta, G. T., Turner, J. R., Taylor, C. T., Hershberg, R. M., Comerford, K., Narravula, S., Podolsky, D. K., & Colgan, S. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1027 · Cited by 449
A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn’s disease
Plevy, S. E., Landers, C. J., Prehn, J., Carramanzana, N. M., Deem, R. L., Shealy, D., & Targan, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.12.6276 · Cited by 385
Cong, Y., Brandwein, S. L., McCabe, R. P., Lazenby, A., Birkenmeier, E. H., Sundberg, J. P., & Elson, C. O. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.855 · Cited by 383
Li, D.-Q., Luo, L., Chen, Z., Kim, H.-S., Song, X. J., & Pflugfelder, S. C. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.08.019 · Cited by 345
Changes in Colonic Mucosal Permeability in Mouse Colitis Induced with Dextran Sulfate Sodium.
KITAJIMA, S., TAKUMA, S., & MORIMOTO, M. (1999) · Experimental Animals · doi:10.1538/expanim.48.137 · Cited by 283
Castaneda, F. E., Walia, B., Vijay–Kumar, M., Patel, N. R., Roser, S., Kolachala, V. L., Rojas, M., Wang, L., Oprea, G., Garg, P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.09.017 · Cited by 267
Self-citationGewirtz, A. T., Collier-Hyams, L. S., Young, A. N., Kucharzik, T., Guilford, W. J., Parkinson, J. F., Williams, I. R., Neish, A. S., & Madara, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5260 · Cited by 256
Odashima, M., Bamias, G., Rivera-Nieves, J., Linden, J., Nast, C. C., Moskaluk, C. A., Marini, M., Sugawara, K., Kozaiwa, K., Otaka, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.032 · Cited by 205
Wirtz, S. J., Finotto, S., Kanzler, S., Lohse, A. W., Blessing, M., Lehr, H. A., Galle, P. R., & Neurath, M. F. (1999) · PubMed · Cited by 179
Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes.
Ni, J., Chen, S. F., & Hollander, D. (1996) · Gut · doi:10.1136/gut.39.2.234 · Cited by 169
Specific Type IV Phosphodiesterase Inhibitor Rolipram Mitigates Experimental Colitis in Mice
Hartmann, G., Bidlingmaier, C., Siegmund, B., Albrich, S., Schulze, J., Tschoep, K., Eigler, A., Lehr, H. A., & Endres, S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35257-7 · Cited by 162
Liu, N., Nguyen, L., Chun, R. F., Lagishetty, V., Ren, S., Wu, S., Hollis, B. W., DeLuca, H. F., Adams, J. S., & Hewison, M. (2008) · Endocrinology · doi:10.1210/en.2008-0060 · Cited by 155
Autoimmune Intestinal Pathology Induced by hsp60-Specific CD8 T Cells
Steinhoff, U., Brinkmann, V., Klemm, U., Aichele, P., Seiler, P. J., Brandt, U., Bland, P. W., Prinz, I., Zügel, U., & Kaufmann, S. H. E. (1999) · Immunity · doi:10.1016/s1074-7613(00)80110-7 · Cited by 135
Adenosine Kinase Inhibitor GP515 Improves Experimental Colitis in Mice
Siegmund, B., Rieder, F., Albrich, S. B., Wolf, K., Bidlingmaier, C., Firestein, G. S., Boyle, D., Lehr, H., Loher, F., Hartmann, G., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29668-3 · Cited by 128
Animal models of inflammatory bowel disease
Hibi∥, T., Ogata, H., & Sakuraba, A. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200060 · Cited by 111
Nemeth, Z. H., Deitch, E. A., Szabó, C., & Haskó, G. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64259-9 · Cited by 101
PACAP provides colonic protection against dextran sodium sulfate induced colitis
Azuma, Y., Hagi, K., Shintani, N., Kuwamura, M., Nakajima, H., Hashimoto, H., Baba, A., & Takeuchi, T. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21381 · Cited by 88
Araki, Y., Andoh, A., Fujiyama, Y., & Bamba, T. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01094.x · Cited by 85
A. Venkatraman, B. S. R. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200451171 · Cited by 83
The aetiopathogenesis of inflammatory bowel disease — immunology and repair mechanisms
Dignass, A. U., Baumgart, D. C., & Sturm, A. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02047.x · Cited by 81
Sartor, R. B., Bond, T., & Schwab, J. H. (1988) · Infection and Immunity · doi:10.1128/iai.56.8.2101-2108.1988 · Cited by 73
Schwartz, L. H., Abolhassani, M., Pooya, M., Steyaert, J., Wertz, X., Israël, M., Guais, A., & Chaumet‐Riffaud, P. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90296.2008 · Cited by 48
The basis of current and future therapy for inflammatory bowel disease
Elson, C. O. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00049-6 · Cited by 36
Cited by
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
“Similarly, although dextran-sulphate sodium (DSS)-induced colitis is associated with increased intestinal permeability, this is the result of widespread epithelial cell damag”
BackgroundDextran Sulfate Sodium (DSS)‐Induced Colitis in Mice
Chassaing, B., Aitken, J. D., Malleshappa, M., & Vijay‐Kumar, M. (2014) · Current Protocols in Immunology · doi:10.1002/0471142735.im1525s104 · Cited by 2,090
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
Johansson, M. E. V., Gustafsson, J. K., Holmén-Larsson, J., Jabbar, K. S., Xia, L., Xu, H., Ghishan, F. K., Carvalho, F. A., Gewirtz, A. T., Sjövall, H., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303207 · Cited by 1,004
Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks
Perše, M., & Cerar, A. (2012) · Journal of Biomedicine and Biotechnology · doi:10.1155/2012/718617 · Cited by 881
Metadata
- Authors
- Yan, Y., Kolachala, V., Dalmasso, G., Nguyen, H., Laroui, H., Sitaraman, S. V., & Merlin, D.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-06-29
- Volume
- 4
- Issue
- 6
- Pages
- e6073
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2005959793
- Cited by
- 410
- References
- 37
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.